3,3'-diindolylmethane has been researched along with Cardiometabolic Syndrome in 1 studies
3,3'-diindolylmethane: anti-inflammatory from edible cruciferous vegetables; a cytochrome P-450 antagonist
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S | 1 |
| Henderson, A | 1 |
| Petriello, MC | 1 |
| Romano, KA | 1 |
| Gearing, M | 1 |
| Miao, J | 1 |
| Schell, M | 1 |
| Sandoval-Espinola, WJ | 1 |
| Tao, J | 1 |
| Sha, B | 1 |
| Graham, M | 1 |
| Crooke, R | 1 |
| Kleinridders, A | 1 |
| Balskus, EP | 1 |
| Rey, FE | 1 |
| Morris, AJ | 1 |
| Biddinger, SB | 1 |
1 other study available for 3,3'-diindolylmethane and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction.
Topics: Animals; eIF-2 Kinase; Gastrointestinal Microbiome; HEK293 Cells; Hep G2 Cells; Humans; Indoles; Ins | 2019 |